Identification of a novel class of RIP1/RIP3 dual inhibitors that impede cell death and inflammation in mouse abdominal aortic aneurysm models
暂无分享,去创建一个
Huan Yang | Jun Ren | Scott A Wildman | Bo Liu | Weiping Tang | S. Wildman | Weiping Tang | Qiwei Wang | Jun Ren | Bo Liu | John B Feltenberger | Zhengqin Ye | Qiwei Wang | Noel Phan | Ting Zhou | Huan Yang | Ting Zhou | Conner C Feldman | Zhengqing Ye | Noel M Phan | Weiping Tang | John B. Feltenberger | Conner C. Feldman
[1] Michelle C. Schaeffer,et al. Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases. , 2017, Journal of medicinal chemistry.
[2] J. Bertin,et al. Genetic Inhibition of Receptor Interacting Protein Kinase-1 Reduces Cell Death and Improves Functional Outcome After Intracerebral Hemorrhage in Mice , 2017, Stroke.
[3] Xiaodong Wang,et al. RIP3-mediated necrotic cell death accelerates systematic inflammation and mortality , 2015, Proceedings of the National Academy of Sciences.
[4] W. Kaiser,et al. DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. , 2012, Cell host & microbe.
[5] Kenta Moriwaki,et al. The RIP1/RIP3 Necrosome Forms a Functional Amyloid Signaling Complex Required for Programmed Necrosis , 2012, Cell.
[6] J. Bertin,et al. K45A mutation of RIPK1 results in poor necroptosis and cytokine signaling in macrophages, which impacts inflammatory responses in vivo , 2016, Cell Death and Differentiation.
[7] Michelle C. Schaeffer,et al. Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with Necroptosis. , 2013, ACS medicinal chemistry letters.
[8] Deepak Bandyopadhyay,et al. DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors. , 2016, Journal of medicinal chemistry.
[9] Yingying Zhang,et al. Distinct roles of RIP1–RIP3 hetero- and RIP3–RIP3 homo-interaction in mediating necroptosis , 2014, Cell Death and Differentiation.
[10] Wei Gan,et al. Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis , 2016, Science Advances.
[11] R. Guha,et al. Profile of the GSK Published Protein Kinase Inhibitor Set Across ATP-Dependent and-Independent Luciferases: Implications for Reporter-Gene Assays , 2013, PloS one.
[12] J. Bertin,et al. Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL* , 2013, The Journal of Biological Chemistry.
[13] Bo Liu,et al. Inhibition of Receptor-Interacting Protein Kinase 1 with Necrostatin–1s ameliorates disease progression in elastase-induced mouse abdominal aortic aneurysm model , 2017, Scientific Reports.
[14] Gerard Manning,et al. Necroptosis and Inflammation. , 2016, Annual review of biochemistry.
[15] M. Pasparakis,et al. Cutting Edge: RIPK1 Kinase Inactive Mice Are Viable and Protected from TNF-Induced Necroptosis In Vivo , 2014, The Journal of Immunology.
[16] Jiahuai Han,et al. RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway , 2014, Nature Immunology.
[17] V. Dixit,et al. Kinase RIP3 Is Dispensable for Normal NF-κBs, Signaling by the B-Cell and T-Cell Receptors, Tumor Necrosis Factor Receptor 1, and Toll-Like Receptors 2 and 4 , 2004, Molecular and Cellular Biology.
[18] S. Morgan,et al. Effects of Caspase Inhibitor on Angiotensin II-Induced Abdominal Aortic Aneurysm in Apolipoprotein E–Deficient Mice , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[19] D. Green,et al. Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis , 2015, Cell Death and Differentiation.
[20] D. Vaux,et al. RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis , 2014, Cell.
[21] Zhenjie Liu,et al. Thrombospondin-1 (TSP1) contributes to the development of vascular inflammation by regulating monocytic cell motility in mouse models of abdominal aortic aneurysm. , 2015, Circulation research.
[22] A. Degterev,et al. Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis. , 2017, Trends in pharmacological sciences.
[23] Z. Miao,et al. The B-RafV600E inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury , 2014, Cell Death and Disease.
[24] A. Ashkenazi,et al. NEMO and RIP1 Control Cell Fate in Response to Extensive DNA Damage via TNF-α Feedforward Signaling , 2011, Cell.
[25] K. Newton. RIPK1 and RIPK3: critical regulators of inflammation and cell death. , 2015, Trends in cell biology.
[26] Junying Yuan,et al. Activation of necroptosis in multiple sclerosis. , 2015, Cell reports.
[27] G. Superti-Furga,et al. A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis , 2015, Cell Death and Disease.
[28] A Daugherty,et al. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. , 2000, The Journal of clinical investigation.
[29] Michelle C. Schaeffer,et al. Characterization of GSK′963: a structurally distinct, potent and selective inhibitor of RIP1 kinase , 2015, Cell Death Discovery.
[30] Bo Liu,et al. Receptor-Interacting Protein Kinase 3 Contributes to Abdominal Aortic Aneurysms via Smooth Muscle Cell Necrosis and Inflammation , 2015, Circulation research.
[31] P. Vandenabeele,et al. Regulated necrosis: the expanding network of non-apoptotic cell death pathways , 2014, Nature Reviews Molecular Cell Biology.
[32] R. Abagyan,et al. Type-II kinase inhibitor docking, screening, and profiling using modified structures of active kinase states. , 2008, Journal of medicinal chemistry.
[33] L. Shewchuk,et al. Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). , 2012, Journal of medicinal chemistry.
[34] A. Stewart,et al. Dabrafenib, an inhibitor of RIP3 kinase-dependent necroptosis, reduces ischemic brain injury , 2018, Neural regeneration research.
[35] A. Degterev,et al. Structure-activity relationship study of novel necroptosis inhibitors. , 2005, Bioorganic & medicinal chemistry letters.
[36] Alexei Degterev,et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury , 2005, Nature chemical biology.
[37] P. Vandenabeele,et al. Regulated necrosis: disease relevance and therapeutic opportunities , 2016, Nature reviews. Drug discovery.
[38] Li Jin,et al. CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress–induced myocardial necroptosis , 2016, Nature Medicine.
[39] Stephen J. Capuzzi,et al. Progress towards a public chemogenomic set for protein kinases and a call for contributions , 2017, bioRxiv.
[40] N. van Bruggen,et al. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury , 2016, Cell Death and Differentiation.
[41] M. Bertrand,et al. When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157 , 2017, Cell Death and Differentiation.
[42] K. Kent,et al. Accelerated aneurysmal dilation associated with apoptosis and inflammation in a newly developed calcium phosphate rodent abdominal aortic aneurysm model. , 2012, Journal of vascular surgery.
[43] Qiao Wu,et al. A role of RIP3-mediated macrophage necrosis in atherosclerosis development. , 2013, Cell reports.
[44] Alexei Degterev,et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. , 2008, Nature chemical biology.
[45] Zhenjie Liu,et al. Monocyte Chemoattractant Protein-1 (MCP-1) Regulates Macrophage Cytotoxicity in Abdominal Aortic Aneurysm , 2014, PloS one.
[46] J. Bertin,et al. Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1. , 2015, Cell reports.
[47] Ethan A Merritt,et al. Sequence determinants of a specific inactive protein kinase conformation. , 2013, Chemistry & biology.
[48] P. Leder,et al. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. , 1998, Immunity.
[49] Stefan Grimm,et al. The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal , 1998 .
[50] Junying Yuan,et al. Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death , 2013, Nature Reviews Molecular Cell Biology.
[51] Sai Zhang,et al. Hypoxia-inducible factor-1 alpha is involved in RIP-induced necroptosis caused by in vitro and in vivo ischemic brain injury , 2017, Scientific Reports.
[52] J. Diehl,et al. The Role of the PERK/eIF2α/ATF4/CHOP Signaling Pathway in Tumor Progression During Endoplasmic Reticulum Stress. , 2016, Current molecular medicine.
[53] Kenta Moriwaki,et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. , 2014, Molecular cell.